Nguyen Viet Nhung

机构：Hanoi Lung Hospital, VNU University of Science · ORCID：0000-0002-5447-133X

发表论文 176 篇 · 总被引 4881 次 · h-index 35

代表论文

• Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 76)
• Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam (2024 · New England Journal of Medicine · 被引 61)
• A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis (2024 · NEJM Evidence · 被引 39)
• Risk-stratified treatment for drug-susceptible pulmonary tuberculosis (2024 · Nature Communications · 被引 28)
• Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 27)
• Target regimen profiles for tuberculosis treatment (2024 · Bulletin of the World Health Organization · 被引 26)